CVS Health Corporation (NYSE:CVS) had its price objective upped by equities researchers at Jefferies Group LLC from $82.00 to $86.00 in a research note issued on Friday. The firm currently has a “hold” rating on the pharmacy operator’s stock. Jefferies Group LLC’s price target indicates a potential upside of 4.07% from the company’s previous close.

CVS has been the topic of a number of other research reports. Needham & Company LLC restated a “hold” rating on shares of CVS Health Corporation in a research report on Sunday, September 10th. ValuEngine downgraded shares of CVS Health Corporation from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. BidaskClub downgraded shares of CVS Health Corporation from a “hold” rating to a “sell” rating in a research report on Friday, August 25th. Guggenheim restated a “buy” rating on shares of CVS Health Corporation in a research report on Monday, July 3rd. Finally, Vetr upgraded shares of CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $87.97 price objective on the stock in a research report on Wednesday, May 24th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $90.35.

CVS Health Corporation (NYSE:CVS) traded down 0.7625% during trading on Friday, hitting $82.0099. 2,310,323 shares of the company’s stock traded hands. The company’s 50 day moving average is $78.80 and its 200-day moving average is $78.96. CVS Health Corporation has a 12 month low of $69.30 and a 12 month high of $90.85. The stock has a market cap of $83.37 billion, a P/E ratio of 16.3366 and a beta of 0.92.

CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The firm had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. During the same quarter in the prior year, the company posted $1.32 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. On average, analysts predict that CVS Health Corporation will post $5.88 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This piece was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.dailypolitical.com/2017/09/15/cvs-health-corporation-cvs-pt-raised-to-86-00.html.

In other CVS Health Corporation news, CFO David M. Denton sold 237,078 shares of CVS Health Corporation stock in a transaction on Monday, September 11th. The shares were sold at an average price of $79.65, for a total value of $18,883,262.70. Following the completion of the transaction, the chief financial officer now directly owns 141,096 shares of the company’s stock, valued at approximately $11,238,296.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Thomas M. Moriarty sold 90,267 shares of CVS Health Corporation stock in a transaction on Monday, September 11th. The stock was sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the completion of the transaction, the executive vice president now directly owns 70,102 shares of the company’s stock, valued at $5,580,820.22. The disclosure for this sale can be found here. Insiders sold a total of 370,510 shares of company stock valued at $29,460,266 over the last three months. Corporate insiders own 0.61% of the company’s stock.

Several large investors have recently modified their holdings of CVS. FMR LLC grew its stake in shares of CVS Health Corporation by 22.0% in the 2nd quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock worth $2,425,920,000 after buying an additional 5,446,930 shares in the last quarter. Boston Partners grew its stake in shares of CVS Health Corporation by 69.1% in the 2nd quarter. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock worth $519,711,000 after buying an additional 2,638,888 shares in the last quarter. Parametric Portfolio Associates LLC grew its stake in shares of CVS Health Corporation by 71.5% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock worth $317,805,000 after buying an additional 1,647,168 shares in the last quarter. LSV Asset Management grew its stake in shares of CVS Health Corporation by 44.2% in the 1st quarter. LSV Asset Management now owns 4,579,916 shares of the pharmacy operator’s stock worth $359,523,000 after buying an additional 1,404,384 shares in the last quarter. Finally, Prudential Financial Inc. grew its stake in shares of CVS Health Corporation by 61.8% in the 2nd quarter. Prudential Financial Inc. now owns 2,946,531 shares of the pharmacy operator’s stock worth $237,078,000 after buying an additional 1,125,400 shares in the last quarter. 81.55% of the stock is owned by institutional investors and hedge funds.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Analyst Recommendations for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.